Gerald G. Long

Skeletal Changes in Rats Given Daily Subcutaneous Injections of Recombinant Human Parathyroid Hormone (1-34) for 2 Years and Relevance to Human Safety

John L. Vahle, Masahiko Sato, Gerald G. Long et al. · Toxicologic Pathology · 2002 · 696 citations · Full text

Medicine, Endocrinology, Bone Metabolism +16

Bone Neoplasms in F344 Rats Given Teriparatide [rhPTH(1-34)] Are Dependent on Duration of Treatment and Dose

John L. Vahle, Gerald G. Long, George E. Sandusky et al. · Toxicologic Pathology · 2004 · 371 citations

Medicine, Oncology, Pharmacology +13

Neuronal Vacuolization and Necrosis Induced by the Noncompetitive N-methyl-d-aspartate (NMDA) Antagonist MK(+)801 (Dizocilpine Maleate): A Light and Electron Microscopic Evaluation of the Rat Retrosplenial Cortex

Andrew S. Fix, Jeffrey W. Horn, Karen A. Wightman et al. · Experimental Neurology · 1993 · 256 citations

Medicine, Neurobiology, Neuroscience +17

Use of Severity Grades to Characterize Histopathologic Changes

Kenneth A. Schafer, John Eighmy, James Fikes et al. · Toxicologic Pathology · 2018 · 217 citations

Medicine, Pathology, Toxicology +13

Comparing the incidence of bone tumors in rats chronically exposed to the selective PTH type 1 receptor agonist abaloparatide or PTH(1–34)

Jacquelin Jolette, Bassem Attalla, Aurore Varela et al. · Regulatory Toxicology and Pharmacology · 2017 · 96 citations · Full text

Medicine, Endocrinology, Pharmacology +15